Shares of Avid Bioservices Inc. (NASDAQ:CDMO) traded today at $32.70, eclipsing its 52-week high. This new high was reached on below average trading volume as 308,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares.
In the past 52 weeks, shares of Avid Bioservices Inc. have traded between a low of $6.99 and a high of $32.70 and is now at $32.60, which is 366% above that low price.
Avid Bioservices Inc. (NASDAQ:CDMO) defies analysts with a current price ($32.60) 52.9% above its average consensus price target of $15.34.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer